Patient treated in Spain proceeds to successful resection
Filed with ASX · · 2 pages · English
✓ The Second patient commercially treated with the OncoSil device at The Hospital Universitario de Fuenlabrada in Madrid, Spain has undergone a successful resection of the primary tumour. ✓ OncoSil is continuing to work with a number of other institutions in Spain to enable increased patient access to treatments with the OncoSil device. Sydney, Australia – 19 July 2022: OncoSil Medical Ltd (ASX: O
Story so far
Earlier from OncoSil Medical
- Bupa UK Approves Reimbursement for OncoSil in the UK
- FY 2023 Strategic Update
- OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC
- Entitlement Offer Results and Shortfall Notification
- OncoSil Entitlement Offer Booklet
Later from OncoSil Medical
- Monthly Activities/Appendix 4C Cash Flow Report
- Investor Presentation
- Appendix 4E Announcement
- OncoSil to Present at South-West Connect ASX Showcase
- OncoSil Receives $832k R&D Tax Incentive
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical